Research, platform deep-dives and company updates on biofabrication, organoids and the shift to human-relevant testing.
PlatformHow the OrgCan™ platform grows 3D organoids directly from patient biopsies to preserve tumour architecture, microenvironment and genetics for precision oncology.
CompanyA look at the 6,000 sq ft Bengaluru facility — three cell-culture labs, a microbial lab, and an analytical suite — built to run complex biofabrication at scale.
From scientific claim substantiation to a bespoke disease model, our scientists work alongside your team.
